CoTherix Inc. (CTRX1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
5000 SHORELINE COURT SOUTH SAN FRANCISCO, CA 94080

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Focuses on licensing, developing and commercializing therapeutic products for the treatment of cardiopulmonary and other chronic diseases. Ventavis, the company's first product, is designed for the treatment of pulmonary arterial hypertension.

View SEC Filings from CTRX1 instead.

View recent insider trading info

Funds Holding CTRX1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTRX1

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALTA BIOPHARMA PARTNERS III LP

CHAMPSI FARAH

DELEAGE JEAN

GRUENER GARRETT

MARDUEL ALIX

NOHRA GUY P

ALTA PARTNERS II INC

HURWITZ EDWARD

PENHOET EDWARD

ALTA PARTNERS III, INC.

  • NO LONGER 10% OWNERNOLONGER 10% OWNERNOLONGER 10% OWNERNOLONGER 10% OWNERNOLONGER 10% OWNERNOLONGER 10% OWNERNOLONGER 10% OWNERNOLONGER 10% OWNERNOLONGER 10% OWNERNOLONGER 10% OWNER
0 2007-01-09 0

HEALY JAMES

SOFINNOVA MANAGEMENT V LLC

SOFINNOVA VENTURE PRINCIPALS V LP

SOFINNOVA VENTURE PARTNERS V LP

SOFINNOVA VENTURE AFFILIATES V LP

  • Director
  • 10% Owner
0 2007-01-09 0

EVNIN LUKE

GADICKE ANSBERT

HENNER DENNIS

  • 10% Owner
0 2007-01-09 0

JANNEY DANIEL

ALTA CALIFORNIA PARTNERS III LP

ALTA CALIFORNIA MANAGEMENT PARTNERS III LLC

ALTA EMBARCADERO PARTNERS III LLC

ALTA BIOPHARMA MANAGEMENT III LLC

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

  • Director
  • 10% Owner
0 2007-01-09 0

MPM BIOVENTURES III QP LP

MPM BIOVENTURES III LP

MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

MPM BIOVENTURES III PARALLEL FUND, LP

MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC

MPM BIOVENTURES III GP LP

MPM BIOVENTURES III LLC

GALAKATOS NICHOLAS

STEINMETZ MICHAEL

WHEELER KURT

  • 10% Owner
0 2007-01-09 0

GRYSKA DAVID W

  • Director
0 2007-01-09 0

SIMON NICHOLAS J III

  • Director
  • 10% Owner
0 2007-01-09 0

CHESS ROBERT

  • Director
0 2007-01-09 0

PENNINGTON JAMES E EVP/CHIEF MEDICAL OFFICER

  • Officer
0 2007-01-09 0

SANTEL DONALD J CHIEF EXECUTIVE OFFICER

  • Officer
0 2007-01-09 0

GRAY SMITH CHRISTINE EXECUTIVE VP, CFO & SECRETARY

  • Officer
0 2007-01-09 0

FELDMAN THOMAS PRESIDENT / CBO

  • Officer
0 2007-01-09 0

GOODWIN BRADFORD S

  • Director
0 2007-01-09 0

DICKINSON KLARA VP, REGULATORY AFFAIRS

  • Officer
0 2007-01-09 0

MAHAFFEY GEORGE W SENIOR VP, SALES AND MARKETING

  • Officer
0 2007-01-09 0

JOSHI ABHAY EVP, CHIEF TECHNICAL OFFICER

  • Officer
0 2007-01-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments